DCN Dx has received a growth equity investment from Martis Capital
DCN Dx, a leading provider of contract development services, has received a growth equity investment from Martis Capital.
DCN Dx offers contract development services for clients seeking to explore, develop and commercialize rapid diagnostic tests related to lateral flow assay. DCN Dx supports an array of customers including global diagnostics manufacturers, nonprofits seeking tests for low-resource settings and start-ups launching diagnostic-based products. Over the past 15 years, DCN Dx has successfully developed more than 100 rapid diagnostic tests for its customers.
Martis Capital is a private equity firm which manages more than US$1.2 billion of equity and is focused exclusively on investing in middle-market growth companies in the healthcare industry.
One of Oaklins’ teams in the USA, together with Pegasus Capital, served as a financial advisor to DCN Dx, in connection with a growth equity investment from Martis Capital.
Talk to the deal team
Bradford A. Adams
Oaklins TM Capital
Michael S. Goldman
Oaklins TM Capital
James McLaren
Oaklins TM Capital
Related deals
Dania Software has been acquired by Omnidocs
The owners of Dania Software A/S have sold the company to Omnidocs.
Learn moreTop Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.
Learn moreSoler & Palau Ventilation has acquired subsidiaries of United Enertech Holdings
Soler & Palau Ventilation, Inc. (S&P) has acquired subsidiaries of United Enertech Holdings, LLC. (UEH). The subsidiaries included Air Conditioning Products, LLC; Air Performance, LLC; Metal Form Manufacturing, LLC; and United Enertech Corp.
Learn more